An Alternative Hepatosafe Treatment in Leprosy
Indian Journal of Drugs in Dermatology · 2016
DOI: 10.4103/2455-3972.184086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Drugs in Dermatology, 2016. Verfasst von Anuradha Ashok Bhide und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Leprosy complicated by hepatitis is one condition wherein the usual multidrug therapy cannot be used and alternate regimens are required. The World Health Organization and the Indian Association of Leprologists have recommended an alternative combination therapy of clarithromycin, ofloxacin, and clofazimine to be prescribed in such cases. However, in some cases, this combination therapy may fail to control or worsen the hepatitis. One such case of leprosy, complicated by hepatitis, who did not tolerate the recommended hepatosafe regimen was successfully treated with monthly rifampicin, ofloxacin, and minocycline, and is hence reported.
Zitieren
APA
Bhide, A. A., Khemani, U. N., Kamath, R. R., Vaidyanathan, V., Ponathil, A. P., & Kura, M. M. (2016). An Alternative Hepatosafe Treatment in Leprosy. Indian Journal of Drugs in Dermatology. https://doi.org/10.4103/2455-3972.184086
Vancouver
Bhide AA, Khemani UN, Kamath RR, Vaidyanathan V, Ponathil AP, Kura MM. An Alternative Hepatosafe Treatment in Leprosy. Indian Journal of Drugs in Dermatology. 2016. doi:10.4103/2455-3972.184086
BibTeX
@article{Bhide2016,
author = {Bhide, Anuradha Ashok and Khemani, Usha N and Kamath, Ratnakar R and Vaidyanathan, Varsha and Ponathil, Abhishek P and Kura, Mahendra M},
title = {An Alternative Hepatosafe Treatment in Leprosy},
journal = {Indian Journal of Drugs in Dermatology},
year = {2016},
doi = {10.4103/2455-3972.184086}
}
EUVIMED